呼吸道合胞病毒季节性对拉丁美洲和加勒比地区被动免疫时机方案的影响——一项横断面建模研究
该研究基于2010—2019年28个国家317,951份呼吸道合胞病毒(RSV)阳性呼吸道样本的监测数据,按气候区刻画RSV季节性,并建模评估不同被动免疫时机与策略对新生儿RSV相关急性下呼吸道感染(ALRI)的预防效果。结果显示RSV流行呈自南向北推进,亚热带气候发病集中于3月至11月,热带全年流行;在80%覆盖率下,温带与热带示范国家通过单克隆抗体分别避免61.3%和55.0%的0至<12月龄RSV-ALRI病例。
要点
- 2010—2019年28国报告317,951份RSV阳性呼吸道样本,RSV阳性率为12.6%。
- RSV流行呈自南向北推进,亚热带气候发病介于3月至11月,热带全年流行。
- 80%覆盖率下,温带与热带示范国家经单克隆抗体分别避免61.3%与55.0%的婴儿RSV-ALRI。
核心结论
- RSV气候差异凸显监测对调整年度免疫运动时机与范围的重要性,RSV季节性可指导干预措施选择,公共卫生举措可通过界定高危婴儿最佳免疫窗口来加强新生儿预防。
研究设计与样本
- 横断面建模研究,利用2010—2019年28个国家的RSV监测数据,按气候区用移动平均法刻画季节性,并在不同保护时长与策略假设下识别符合被动免疫条件的新生儿。
主要发现
- 2010—2019年28个国家报告317,951份RSV阳性呼吸道样本,RSV阳性率为12.6%。
- RSV流行呈自南向北推进,亚热带气候发病介于3月至11月,热带呈全年流行。
- 季节性免疫使温带国家1月至9月出生的新生儿获益,热带全年出生者至少在一个流行季获得免疫获益。
- 在80%覆盖率下,温带与热带示范国家通过单克隆抗体分别避免61.3%(95%CI 60.7-67)与55.0%(95%CI 55.0-56.0)的0至<12月龄RSV-ALRI病例。
- 亚热带国家联合RSV母体疫苗与长效单克隆抗体避免57.3%(95%CI 56.8-57.8)的RSV-ALRI。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The variation in respiratory syncytial virus (RSV) seasonality presents challenges for the timing of RSV prophylaxis. Prevention policies must consider seasonal dynamics to protect infants from severe RSV infections. We evaluated the timing and impact of passive immunisation on birth cohorts in Latin America and the Caribbean, accounting for RSV seasonality, duration of protection and uptake. METHODS: We characterised the 2010-2019 RSV seasonality by climate region using a moving averages-based method and surveillance data and identified newborns eligible for passive RSV immunisation under varied assumptions of protection duration and strategies. Lastly, we explored different intervention time windows and estimated RSV-associated acute lower respiratory infections (ALRI) averted among newborns. FINDINGS: In 2010-2019, 28 countries reported 317,951 RSV-positive respiratory samples (12.6 % RSV positivity). RSV epidemics followed a south-to-north progression, with onset ranging from March to November in subtropical climates, and year-round epidemics in the tropics. Seasonal immunisation benefited newborns born during January-September in temperate countries, while those born year-round in the tropics benefited from immunisation during at least one epidemic. Year-round vaccination covered newborns for at least one season; long-acting monoclonal antibodies (mAb) administered at five months to infants of immunised mothers extended protection through the remaining season. Year-round campaigns suited tropical climates. At 80 % coverage, 61.3 % (95 % CI 60.7-67) and 55 % (95 % CI 55.0-56.0) RSV-ALRI cases among 0- < 12 months were averted through mAb in exemplar temperate and tropical countries, respectively. In subtropical countries, combined RSV maternal vaccination and long-acting mAb averted 57.3 % (95 %CI:56.8-57.8) of RSV-ALRI. Efficiency per 100,000 doses administered varied minimally across strategies. CONCLUSIONS: RSV climatic variations underscored the importance of surveillance in tailoring the timing and extent of annual campaigns. RSV seasonality informs the selection of interventions. Public health initiatives can enhance prevention for newborns by defining optimal windows for immunising at-risk-infants.
引用
- Couto P, Campbell H, Li Y, et al. Implications of respiratory syncytial virus seasonality for the timing of passive immunisation scenarios in Latin America and the caribbean - a cross-sectional modelling study. Vaccine. 2025. PMID: 41205406. doi:10.1016/j.vaccine.2025.127934
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。